Biagi M, Rigillo G, Sarill M, Collotta D, Di Giacomo S, Di Sotto A, et al
111 While most studies have reported weight gain associated with their use, 112114 only a few reveal increasing anthropometric parameters without significant modifications in total body weight
An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings
ADJUST-T1D, an investigator-initiated double-blind randomized phase 2 study, assessed the efficacy of once-weekly semaglutide as add-on therapy in individuals aged 1865 years who had been living with type 1 diabetes for more than a year, had inadequate glycemic management (A1C 7%10%) despite AID therapy for more than three months, and a body mass index (BMI) 30 kg/m 2
PlexusDx is not the merchant of record for any prescription medication
The study positions predictive genomic screening as both a clinical opportunity and a systems challenge